The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor evaluation in the field of R&D projects with anti-infective peptides as of January 2009. Stages of the anti-infective peptide R&D projects range from early research to market. Anti-Viral Peptides Anti-viral peptides are used to treat infections such as HIV and AIDS, influenza incl. H5N1 strains, hepatitis C virus infections (HCV). Anti-Bacterial Peptides Anti-bacterial peptides are used to treat infectious diseases such as complicated skin and skin structure infections (cSSSI), gram+ and gram- infections, prevention of catheter-related infections, otitis media, gingivitis and many more. Anti-Fungal Peptides Anti-fungal peptides are used to treat infections such as oesophageal candidiasis, aspergillosis, oral candida infections, vaginal yeast infections and many more The report includes a compilation of current active projects in research and development of anti-infective peptides. In addition, the report lists company-specific R&D pipelines of anti-infective peptides. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action, Class of Compound, Company, Product Category, Indication, R&D Stage and additional comments with a hyperlink leading to the source of information. Index Anti-Bacterial Peptides Anti-Viral Peptides Anti-Fungal Peptides Corporate PTH Receptor Agonist R&D Pipelines About La Merie Corporate PTH Receptor Agonist R&D Pipelines Alfacell AM-Pharma Ambrilia Astellas Pharma AstraZeneca Cadence Pharmaceuticals Cubist Pharmaceuticals Demegen Digna Biotech Dynamic Microbials FusoGen Pharmaceutical Genaera Green Cross Helix BioMedix ImmuneRegen Biosciences ImmuPharma Inimed Pharmaceuticals Lytix Biopharma MacroChem Merck & Co. Migenix Novacta Novartis Novexel Novozymes OctoPlus ONI Biopharma OyaGen Pacgen PepTx Pfizer RecombinoGen Roche SciClone Pharmaceuticals Sigma-Tau SpiderBiotech Targanta Theravance Tohoku University Trimeris University of Western Ontario University of Wisconsin Viral Genetics Xigen XOMA

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Competitor Analysis: Anti-Infective Peptides
Published on January 2009
Report Summary
The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a
competitor evaluation in the field of R&D projects with anti-infective peptides as of January 2009. Stages of the anti-infective peptide
R&D projects range from early research to market. Anti-Viral Peptides
Anti-viral peptides are used to treat infections such as HIV and AIDS, influenza incl. H5N1 strains, hepatitis C virus infections (HCV).
Anti-Bacterial Peptides
Anti-bacterial peptides are used to treat infectious diseases such as complicated skin and skin structure infections (cSSSI), gram+
and gram- infections, prevention of catheter-related infections, otitis media, gingivitis and many more. Anti-Fungal Peptides
Anti-fungal peptides are used to treat infections such as oesophageal candidiasis, aspergillosis, oral candida infections, vaginal yeast
infections and many more
The report includes a compilation of current active projects in research and development of anti-infective peptides. In addition, the
report lists company-specific R&D pipelines of anti-infective peptides. Competitor projects are listed in a tabular format providing
information on:
Drug Codes, Target / Mechanism of Action, Class of Compound, Company, Product Category, Indication,
R&D Stage and additional comments with a hyperlink leading to the source of information. Index Anti-Bacterial
Peptides Anti-Viral Peptides Anti-Fungal Peptides Corporate PTH Receptor Agonist R&D Pipelines About La Merie
Corporate PTH Receptor Agonist R&D Pipelines Alfacell AM-Pharma Ambrilia Astellas Pharma AstraZeneca Cadence
Pharmaceuticals Cubist Pharmaceuticals Demegen Digna Biotech Dynamic Microbials FusoGen Pharmaceutical Genaera
Green Cross Helix BioMedix ImmuneRegen Biosciences ImmuPharma Inimed Pharmaceuticals Lytix Biopharma
MacroChem Merck & Co. Migenix Novacta Novartis Novexel Novozymes OctoPlus ONI Biopharma OyaGen
Pacgen PepTx Pfizer RecombinoGen Roche SciClone Pharmaceuticals Sigma-Tau SpiderBiotech Targanta
Theravance Tohoku University Trimeris University of Western Ontario University of Wisconsin Viral Genetics Xigen
XOMA
Competitor Analysis: Anti-Infective Peptides Page 1/3

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Competitor Analysis: Anti-Infective Peptides
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 375.00 Quantity: _____
Site License--USD 750.00 Quantity: _____
Corporate License--USD 1 125.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Competitor Analysis: Anti-Infective Peptides Page 2/3

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Competitor Analysis: Anti-Infective Peptides Page 3/3